Steven Kesten - Net Worth and Insider Trading
Steven Kesten Net Worth
The estimated net worth of Steven Kesten is at least $1 dollars as of 2024-11-13. Steven Kesten is the Exec VP and Chief MO of Plus Therapeutics Inc and owns about 1 shares of Plus Therapeutics Inc (PSTV) stock worth over $1. Details can be seen in Steven Kesten's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven Kesten has not made any transactions after 2015-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steven Kesten
Steven Kesten Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven Kesten owns 1 companies in total, including Plus Therapeutics Inc (PSTV) .
Click here to see the complete history of Steven Kesten’s form 4 insider trades.
Insider Ownership Summary of Steven Kesten
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PSTV | Plus Therapeutics Inc | 2015-08-19 | Exec VP and Chief MO |
Steven Kesten Latest Holdings Summary
Steven Kesten currently owns a total of 1 stock. Steven Kesten owns 1 shares of Plus Therapeutics Inc (PSTV) as of August 19, 2015, with a value of $1.
Latest Holdings of Steven Kesten
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PSTV | Plus Therapeutics Inc | 2015-08-19 | 1 | 1.29 | 1 |
Holding Weightings of Steven Kesten
Steven Kesten Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven Kesten has made a total of 0 transactions in Plus Therapeutics Inc (PSTV) over the past 5 years. The most-recent trade in Plus Therapeutics Inc is the acquisition of 1 shares on August 19, 2015, which cost Steven Kesten around $2,340.
Insider Trading History of Steven Kesten
- 1
Steven Kesten Trading Performance
GuruFocus tracks the stock performance after each of Steven Kesten's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven Kesten is -13.92%. GuruFocus also compares Steven Kesten's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven Kesten within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven Kesten's insider trading performs compared to the benchmark.
Performance of Steven Kesten
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.8 | | | | | |
| Relative Return to S&P 500(%) | 9.65 | | | | | |
Steven Kesten Ownership Network
Ownership Network List of Steven Kesten
Ownership Network Relation of Steven Kesten
Steven Kesten Owned Company Details
What does Plus Therapeutics Inc do?
Who are the key executives at Plus Therapeutics Inc?
Steven Kesten is the Exec VP and Chief MO of Plus Therapeutics Inc. Other key executives at Plus Therapeutics Inc include President Marc H Hedrick , Chief Financial Officer Sims Andrew John Hugh Macintyre , and CHIEF MEDICAL OFFICER Norman D. Lafrance .
Plus Therapeutics Inc (PSTV) Insider Trades Summary
Over the past 18 months, Steven Kesten made no insider transaction in Plus Therapeutics Inc (PSTV). Other recent insider transactions involving Plus Therapeutics Inc (PSTV) include a net purchase of 28,761 shares made by Robert P Lenk , a net purchase of 22,797 shares made by Howard Clowes , and a net purchase of 44,755 shares made by Greg Petersen .
In summary, during the past 3 months, insiders sold 0 shares of Plus Therapeutics Inc (PSTV) in total and bought 39,883 shares, with a net purchase of 39,883 shares. During the past 18 months, 2,068 shares of Plus Therapeutics Inc (PSTV) were sold and 140,755 shares were bought by its insiders, resulting in a net purchase of 138,687 shares.
Plus Therapeutics Inc (PSTV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Plus Therapeutics Inc Insider Transactions
Steven Kesten Mailing Address
Above is the net worth, insider trading, and ownership report for Steven Kesten. You might contact Steven Kesten via mailing address: 3020 Callan Road, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
